Chiesi Group receives European Marketing Authorisation for its triple combination therapy...

Chronic obstructive pulmonary disease (COPD) patients for whom a dry powder inhaler device is preferred, can now benefit from an extrafine...

1/21

D&I Policy: a further demonstration of Chiesi's commitment

2/21

New record for the Chiesi Group, which is confirmed top Italian pharmaceutical company for number...

3/21

ARCHIVE NEWS

Chiesi continues cultural transformation with new visual identity that mirrors patients’ language and experiences

22 March 2021

The Chiesi Group is on Twitter!

17 March 2021

Chiesi Group: performance is up in 2020

09 March 2021

Chiesi Group receives the European marketing authorisation for Trimbow® (beclometasone dipropionate, formoterol fumarate, glycopyrronium) an extrafine formulation fixed triple combination therapy for the treatment of asthma

01 February 2021

Chiesi Headquarters: an innovative, sustainable and people-friendly “home”, the first building in its category to be certified “LEED Platinum” in Italy. A people-oriented project.

27 January 2021

“Infermieri, a viso aperto”, a photographic project bringing to light the faces and stories of those who help patients every day

14 January 2021

Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets

30 November 2020

Chiesi Group receives Diversity Leaders Award 2021

19 November 2020

World Prematurity Day: Chiesi is at the forefront for preterm babies

17 November 2020

Chiesi launches “The Art of Caring”, a journey in search of the link between Parma, officinal treatments and pharmaceutics

17 November 2020

Chiesi USA, Inc. announces FDA approval of Bronchitol® (mannitol) inhalation powder

02 November 2020

Maria Paola Chiesi received by the President of the Italian Republic for the 2020 Bellisario Award ceremony

15 October 2020

Regeneration 20|3, the first global meeting to launch the program is in Parma on October 15 and 16.

06 October 2020

Italy for Climate: Chiesi at the forefront for the future of Italy

01 October 2020

We ACT Day 2020: the third edition of Chiesi’s event for a sustainable future

24 September 2020

Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH).

18 September 2020

Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID-19 pandemic

30 March 2020

Chiesi Group Announces Establishment of New Global Rare Diseases Division

06 February 2020

10, Venezuela Str, District 1 01183 Bucuresti, Romania
Phone +40 (21) 202 36 42
office.ro(at)chiesi.com

CHIESI ON THE WEB